Status:
UNKNOWN
Use of Transcranial Magnetic Stimulation and Constraint Induced Movement Therapy in Pediatric Unilateral Cerebral Palsy
Lead Sponsor:
University of Manitoba
Conditions:
Cerebral Palsy
Eligibility:
All Genders
18-5 years
Phase:
NA
Brief Summary
Cerebral Palsy (CP) is the most common cause of childhood physical disability. Early CP diagnosis and intervention are crucial to improving outcomes in these patients. Constraint-induced movement ther...
Detailed Description
Cerebral Palsy (CP) is the most common cause of childhood physical disability. Early CP diagnosis and intervention are crucial in optimizing neuroplasticity and improving outcomes. One such interventi...
Eligibility Criteria
Inclusion
- diagnosis of unilateral spastic CP
- assessed as Gross Motor Function Classification System level I to III
- assessed as Manual Ability Classification System level II to level IV
Exclusion
- have received CIMT in the last 6 month
- do not have neuroimaging studies to confirm clinical diagnosis of CP
- severe impairments limiting their ability to participate
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04902521
Start Date
June 1 2022
End Date
December 1 2023
Last Update
June 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SSCY/RCC
Winnipeg, Manitoba, Canada, R3E3G1